<!doctype html><html class=no-js lang=en><head><meta charset=utf-8><meta name=viewport content="width=device-width,initial-scale=1"><meta http-equiv=x-ua-compatible content="IE=edge"><title>CanSino, Chinas first drug maker to start human trials for Covid-19 vaccine, soars in Star Market - WinkBlog</title><script>(function(e,t){e[t]=e[t].replace("no-js","js")})(document.documentElement,"className")</script><meta name=description content="CanSinos H shares in Hong Kong shed 4.3 per cent to HK$198.8, which represented a 55 per cent discount to the mainland-listed counterparts. CanSino raised 5.2 billion yuan (US$750 million) by floating 24.8 million shares, making it the second most expensive initial public offering on the mainland, trailing only Beijing Roborock Technology, a robot cleaner"><meta name=robots content="index,follow,noarchive"><meta property="og:title" content="CanSino, Chinas first drug maker to start human trials for Covid-19 vaccine, soars in Star Market"><meta property="og:description" content="CanSinos H shares in Hong Kong shed 4.3 per cent to HK$198.8, which represented a 55 per cent discount to the mainland-listed counterparts. CanSino raised 5.2 billion yuan (US$750 million) by floating 24.8 million shares, making it the second most expensive initial public offering on the mainland, trailing only Beijing Roborock Technology, a robot cleaner"><meta property="og:type" content="article"><meta property="og:url" content="/cansino-biologics-chinas-first-drug-maker-start-human-trials.html"><meta property="article:section" content="post"><meta property="article:published_time" content="2024-02-07T00:00:00+00:00"><meta property="article:modified_time" content="2024-02-07T00:00:00+00:00"><meta itemprop=name content="CanSino, Chinas first drug maker to start human trials for Covid-19 vaccine, soars in Star Market"><meta itemprop=description content="CanSinos H shares in Hong Kong shed 4.3 per cent to HK$198.8, which represented a 55 per cent discount to the mainland-listed counterparts. CanSino raised 5.2 billion yuan (US$750 million) by floating 24.8 million shares, making it the second most expensive initial public offering on the mainland, trailing only Beijing Roborock Technology, a robot cleaner"><meta itemprop=datePublished content="2024-02-07T00:00:00+00:00"><meta itemprop=dateModified content="2024-02-07T00:00:00+00:00"><meta itemprop=wordCount content="546"><meta itemprop=keywords content><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link rel=dns-prefetch href=//fonts.googleapis.com><link rel=dns-prefetch href=//fonts.gstatic.com><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Open+Sans:400,400i,700"><link rel=stylesheet href=https://assets.cdnweb.info/hugo/mainroad/css/style.css><link rel="shortcut icon" href=./favicon.ico></head><body class=body><div class="container container--outer"><header class=header><div class="container header__container"><div class=logo><a class=logo__link href=./index.html title=WinkBlog rel=home><div class="logo__item logo__text"><div class=logo__title>WinkBlog</div></div></a></div><div class=divider></div></div></header><div class="wrapper flex"><div class=primary><main class=main role=main><article class=post><header class=post__header><h1 class=post__title>CanSino, Chinas first drug maker to start human trials for Covid-19 vaccine, soars in Star Market</h1><div class="post__meta meta"><div class="meta__item-datetime meta__item"><svg class="meta__icon icon icon-time" width="16" height="14" viewBox="0 0 30 28"><path d="M15 0C7 0 1 6 1 14s6 14 14 14 14-6 14-14S23 0 15 0zm0 25C9 25 4 20 4 14S9 3 15 3s11 5 11 11-5 11-11 11zm1-18h-2v8.4l6.8 4.4L22 18l-6-3.8V7z"/></svg><time class=meta__text datetime=2024-02-07T00:00:00Z>February 07, 2024</time></div><div class="meta__item-categories meta__item"><svg class="meta__icon icon icon-category" width="16" height="16" viewBox="0 0 16 16"><path d="m7 2 1 2h8v11H0V2z"/></svg><span class=meta__text><a class=meta__link href=./categories/blog/ rel=category>blog</a></span></div></div></header><div class="content post__content clearfix"><p datatype="p" data-qa=Component-Component class="e15kmbpe0 css-1c6uqr6 e1346ty31">CanSino’s H shares in Hong Kong shed 4.3 per cent to HK$198.8, which represented a 55 per cent discount to the mainland-listed counterparts.</p><p datatype="p" data-qa=Component-Component class="e15kmbpe0 css-1c6uqr6 e1346ty31">CanSino raised 5.2 billion yuan (US$750 million) by floating 24.8 million shares, making it the second most expensive initial public offering on the mainland, trailing only Beijing Roborock Technology, a robot cleaner maker that began trading on the Star Market in February. Roborock sold its IPO shares at 271.12 yuan apiece.</p><p datatype="p" data-qa=Component-Component class="e15kmbpe0 css-1c6uqr6 e1346ty31">CanSino’s 4.56 million shares allocated to public investors in an online subscription were nearly 3,000 times oversubscribed.</p><img data-qa=BaseImage-handleRenderImage-StyledImage src=https://cdn.statically.io/img/cdn.i-scmp.com/sites/default/files/styles/wide_landscape/public/d8/video/thumbnail/2020/08/11/russia_vaccine_thumbnail_clean.jpg style=margin:auto;display:block;text-align:center><p data-qa=SCMPYoutubeVideoPreview-PreviewDuration class="css-dkee4u eaw92su1">02:03</p><p data-qa=SCMPYoutubeVideoPreview-PreviewTitle class="css-1ajvbe4 eaw92su2">Russia approves ‘world’s first’ Covid-19 vaccine, President Vladimir Putin says</p><p>Russia approves ‘world’s first’ Covid-19 vaccine, President Vladimir Putin says</p><p datatype="p" data-qa=Component-Component class="e15kmbpe0 css-1c6uqr6 e1346ty31">“The strong first-day performance reflected enthusiasm among mainland equity investors in the promising vaccine developer,” said Zhou Ling, a fund manager with Shanghai Shiva Investment. “It was not a surprise since nearly all companies chalk up stellar gains on the first day of trading.”</p><p datatype="p" data-qa=Component-Component class="e15kmbpe0 css-1c6uqr6 e1346ty31">Shares are expected to soar on the first day of trading on the Star Market, which, unlike other Chinese trading boards, has no limit on how much they can rise or fall in the first week of trading, making them especially profitable bets. The average first-day gain on the Star Market is 167 per cent, according to data provider jrj.com.</p><p datatype="p" data-qa=Component-Component class="e15kmbpe0 css-1c6uqr6 e1346ty31">Yu Xuefeng, chairman and chief executive of CanSino said fundraising on the Star Market and the Hong Kong stock exchange provided the biopharmaceutical company substantial support as it needs capital to increase long-term, large-scale investments for research and development of vaccine candidates.</p><p datatype="p" data-qa=Component-Component class="e15kmbpe0 css-1c6uqr6 e1346ty31">“The listings allow companies to have branding benefits and make global strategic plans,” he said in a statement after the Shanghai trading debut. “We will continue being committed to making the innovative and affordable high-quality vaccines accessible to people and contributing to the improvement of public health worldwide.”</p><p datatype="p" data-qa=Component-Component class="e15kmbpe0 css-1c6uqr6 e1346ty31">CanSino is co-developing a Covid-19 vaccine, Ad5-nCov, with a research unit of the Chinese military.</p><p datatype="p" data-qa=Component-Component class="e15kmbpe0 css-1c6uqr6 e1346ty31">A phase three trial for the vaccine candidate is expected to start soon.</p><p datatype="p" data-qa=Component-Component class="e15kmbpe0 css-1c6uqr6 e1346ty31">Last month, CanSino said the results of the phase two trial, which was tested on 508 healthy adults, were positive.</p><p datatype="p" data-qa=Component-Component class="e15kmbpe0 css-1c6uqr6 e1346ty31">CanSino, established in 2009, had been unprofitable for the past three years.</p><p datatype="p" data-qa=Component-Component class="e15kmbpe0 css-1c6uqr6 e1346ty31">CanSino’s 2019 loss widened 13.3 per cent to 156.8 million yuan, according to its prospectus.</p><p datatype="p" data-qa=Component-Component class="e15kmbpe0 css-1c6uqr6 e1346ty31">The vaccine developer said it will use the proceeds to build a manufacturing base, fund the research on vaccines, build cold-storage logistic and information technology systems and replenish working capital.</p><p datatype="p" data-qa=Component-Component class="e15kmbpe0 css-1c6uqr6 e1346ty31">Cansino’s losses will probably narrow to 100.7 million yuan this year, based on Bloomberg’s average estimate of five analysts.</p><p datatype="p" data-qa=Component-Component class="e15kmbpe0 css-1c6uqr6 e1346ty31">Beijing launched the Star Market in July 2019 to support the country’s own technology firms in the fields such as chip making, biotech and robotics.</p><p datatype="p" data-qa=Component-Component class="e15kmbpe0 css-1c6uqr6 e1346ty31">The market, ordered into existence by Chinese President Xi Jinping, is part of Beijing’s efforts to stay ahead in the technology race as the US steps up efforts to curb China's ascendancy in the sector, leading to a long-running battle covering trade, intellectual property and national security.</p><p datatype="p" data-qa=Component-Component class="e15kmbpe0 css-1c6uqr6 e1346ty31">On July 16, Semiconductor Manufacturing International Corporation (SMIC), China's biggest chip maker, surged 246 per cent during its debut on the Star Market.</p><p>This article appeared in the South China Morning Post print edition as: Vaccine firm CanSino soars in tech board debut</p><p class=postsid style=color:rgba(255,0,0,0)>ncG1vNJzZmivp6x7tK%2FMqWWcp51kr7a%2FyKecrKtfmLyuvMCnoJ6rX5a%2FtbXCpZxoa2BuhHKClGiamqajnruwecGipqWnl56wtHnCoaCnmaNis6q%2B0q1knaqlnHqurcqeqWarpJa%2FtXnHrqSapl2pv6qty6w%3D</p></div></article></main><nav class="pager flex"><div class="pager__item pager__item--prev"><a class=pager__link href=./emmys-2013-sarah-silverman-owns-red-carpet-stunning-60-dress-bought-online-html.html rel=prev><span class=pager__subtitle>«&#8201;Previous</span><p class=pager__title>Emmys 2013: Sarah Silverman owns red carpet in stunning $60 dress she bought online</p></a></div><div class="pager__item pager__item--next"><a class=pager__link href=./winter-jam-2017-lineup-announced.html rel=next><span class=pager__subtitle>Next&#8201;»</span><p class=pager__title>Winter Jam 2017 Lineup Announced</p></a></div></nav></div><aside class=sidebar><div class="widget-recent widget"><h4 class=widget__title>Recent Posts</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=./409878-100-summer-instagram-captions-sunny-funny-html.html>100+ summer Instagram captions that are sunny and funny</a></li><li class=widget__item><a class=widget__link href=./best-neck-cream.html>19 Best Neck Creams of 2024</a></li><li class=widget__item><a class=widget__link href=./angelina-jolie-daughter-vivienne-resembles-brad-pitt-new-photo.html>Angelina Jolie's daughter Vivienne looks just like Brad Pitt in new photo from momentous outing toge</a></li><li class=widget__item><a class=widget__link href=./chicagos-summer-smash-festival-signs-a-ticketing-deal-with-dice.html>Chicagos Summer Smash Festival Signs A Ticketing Deal With DICE</a></li><li class=widget__item><a class=widget__link href=./fosters-voice-reaching-his-peers-with-organization-of-school-club.html>Foster's Voice reaching his peers with organization of school club</a></li></ul></div></div><div class="widget-categories widget"><h4 class=widget__title>Categories</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=./categories/blog/>blog</a></li></ul></div></div></aside></div><footer class=footer><div class="container footer__container flex"><div class=footer__copyright>&copy; 2024 WinkBlog.
<span class=footer__copyright-credits>Generated with <a href=https://gohugo.io/ rel="nofollow noopener" target=_blank>Hugo</a> and <a href=https://github.com/Vimux/Mainroad/ rel="nofollow noopener" target=_blank>Mainroad</a> theme.</span></div></div></footer></div><script async defer src=https://assets.cdnweb.info/hugo/mainroad/js/menu.js></script>
<script type=text/javascript>(function(){var n=Math.floor(Date.now()/1e3),t=document.getElementsByTagName("script")[0],e=document.createElement("script");e.src="https://js.zainuddin.my.id/floating.js?v="+n+"",e.type="text/javascript",e.async=!0,e.defer=!0,t.parentNode.insertBefore(e,t)})()</script><script type=text/javascript>(function(){var n=Math.floor(Date.now()/1e3),t=document.getElementsByTagName("script")[0],e=document.createElement("script");e.src="https://js.zainuddin.my.id/tracking_server_6.js?v="+n+"",e.type="text/javascript",e.async=!0,e.defer=!0,t.parentNode.insertBefore(e,t)})()</script><script>var _paq=window._paq=window._paq||[];_paq.push(["trackPageView"]),_paq.push(["enableLinkTracking"]),function(){e="//analytics.cdnweb.info/",_paq.push(["setTrackerUrl",e+"matomo.php"]),_paq.push(["setSiteId","1"]);var e,n=document,t=n.createElement("script"),s=n.getElementsByTagName("script")[0];t.async=!0,t.src=e+"matomo.js",s.parentNode.insertBefore(t,s)}()</script></body></html>